Patient preferences on rheumatoid arthritis second-line treatment: a discrete choice experiment of Swedish patients
Abstract Background Preference assessments of patients with rheumatoid arthritis can support clinical therapeutic decisions for including biologic and targeted synthetic medicines to use. This study assesses patient preferences for attributes of second-line therapies and heterogeneity within these p...
Main Authors: | Karin Schölin Bywall, Ulrik Kihlbom, Mats Hansson, Marie Falahee, Karim Raza, Eva Baecklund, Jorien Veldwijk |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-020-02391-w |
Similar Items
-
Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations
by: Gwenda Simons, et al.
Published: (2022-02-01) -
Patients accept therapy using embryonic stem cells for Parkinson’s disease: a discrete choice experiment
by: Karin Schölin Bywall, et al.
Published: (2023-10-01) -
Patient Preference for Self-Injection Devices in Rheumatoid Arthritis: A Discrete Choice Experiment in China
by: Wei Y, et al.
Published: (2022-08-01) -
Doctors’ preferences in de-escalating DMARDs in rheumatoid arthritis: a discrete choice experiment
by: T. Martijn Kuijper, et al.
Published: (2017-04-01) -
Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment
by: van Heuckelum M, et al.
Published: (2019-07-01)